Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
NUVA [NASD]
NuVasive, Inc.
Index- P/E- EPS (ttm)-0.20 Insider Own0.90% Shs Outstand46.97M Perf Week3.87%
Market Cap1.68B Forward P/E24.83 EPS next Y1.44 Insider Trans-6.21% Shs Float46.20M Perf Month-1.24%
Income-8.80M PEG- EPS next Q0.25 Inst Own97.60% Short Float5.57% Perf Quarter4.75%
Sales728.10M P/S2.30 EPS this Y142.90% Inst Trans0.07% Short Ratio8.03 Perf Half Y5.24%
Book/sh13.23 P/B2.70 EPS next Y28.02% ROA-0.70% Target Price43.88 Perf Year41.17%
Cash/sh5.27 P/C6.79 EPS next 5Y12.45% ROE-1.50% 52W Range25.07 - 39.89 Perf YTD10.52%
Dividend- P/FCF28.30 EPS past 5Y17.30% ROI3.20% 52W High-10.43% Beta1.06
Dividend %- Quick Ratio2.70 Sales past 5Y22.30% Gross Margin75.20% 52W Low42.52% ATR1.09
Employees1358 Current Ratio3.70 Sales Q/Q15.10% Oper. Margin6.10% RSI (14)54.14 Volatility3.79% 3.15%
OptionableYes Debt/Eq0.57 EPS Q/Q40.00% Profit Margin-1.20% Rel Volume0.58 Prev Close35.29
ShortableYes LT Debt/Eq0.57 EarningsOct 30 AMC Payout- Avg Volume320.37K Price35.73
Recom2.00 SMA201.70% SMA500.12% SMA2000.63% Volume184,656 Change1.25%
30-Sep-14Upgrade Brean Capital Hold → Buy $44
21-May-14Downgrade Needham Buy → Hold
30-Apr-14Reiterated RBC Capital Mkts Sector Perform $35 → $39
30-Apr-14Reiterated Canaccord Genuity Buy $51 → $48
22-Jan-14Reiterated Canaccord Genuity Buy $34 → $51
16-Jan-14Reiterated Barclays Equal Weight $35 → $38
09-Jan-14Reiterated Barclays Equal Weight $32 → $35
02-Dec-13Reiterated Barclays Equal Weight $30 → $32
15-Nov-13Reiterated Barclays Equal Weight $28 → $30
30-Oct-13Reiterated Needham Buy $28 → $35
30-Oct-13Reiterated Barclays Equal Weight $23 → $28
08-Aug-13Initiated Needham Buy $28
31-Jul-13Reiterated Canaccord Genuity Buy $29 → $32
19-Jun-13Reiterated Canaccord Genuity Buy $24.50 → $29
17-May-13Initiated WallachBeth Buy $27
27-Feb-13Reiterated RBC Capital Mkts Sector Perform $18 → $21
27-Feb-13Reiterated Barclays Equal Weight $17 → $19
27-Feb-13Downgrade Mizuho Buy → Neutral
09-Jan-13Upgrade RBC Capital Mkts Underperform → Sector Perform $16 → $18
04-Oct-12Reiterated Mizuho Buy $26 → $20
16-Oct-14 04:30PM  NuVasive Announces Conference Call and Webcast of Third Quarter 2014 Results Marketwired
01-Oct-14 08:30AM  NuVasive(R) Demonstrates Expanding EMEA Business at Eurospine 2014 With Surgeon Workshops and Innovative Product Exhibition Marketwired
30-Sep-14 09:31AM  Will This Analyst Upgrade Help NuVasive (NUVA) Stock Today? at TheStreet
08:40AM  Analysts' Actions: China Mobile Games, Kellogg, Nuvasive and More TheStreet
06:05AM  NuVasive upgraded by Brean Capital Briefing.com
16-Sep-14 12:50PM  St. Jude Medical Gets Award for Leadless Pacemaker Again Zacks
08-Sep-14 03:50PM  Is Abaxis (ABAX) a Buy After Solid Q2 Earnings? Zacks
10:37AM  NuVasive Spine Foundation(TM) Exceeds $13 Million in Global Effort to Support Patients in Need Marketwired
27-Aug-14 12:30PM  Greatbatch to See Sluggish Top Line Growth Zacks
25-Aug-14 03:45PM  ResMed Continues to Disappoint despite OSA Market Potential Zacks
05-Aug-14 04:30PM  NuVasive(R) to Participate in Investor Events in August and September 2014 Marketwired
01:04PM  NUVASIVE INC Financials EDGAR Online Financials
04-Aug-14 04:31PM  NUVASIVE INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
01-Aug-14 12:14PM  Bob McNamara, the Executive Vice President and CFO of LDR Holding Corporation (LDRH), Interviews with The Wall Street Transcript Wall Street Transcript
10:04AM  Insider Trading Alert - REX, NUVA And CIEN Traded By Insiders at TheStreet
30-Jul-14 09:22AM  Will This Price Target Increase Help NuVasive (NUVA) Stock Today? at TheStreet +9.01%
29-Jul-14 05:30PM  NuVasive Inc Earnings Call scheduled for 5:30 pm ET today CCBN
04:34PM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:30PM  NuVasive Reports Second Quarter 2014 Financial Results and Increases Full Year Guidance Marketwired
07:07AM  Q2 2014 NuVasive CCBN
15-Jul-14 04:30PM  NuVasive(R) Announces Conference Call and Webcast of Second Quarter 2014 Results Marketwired
14-Jul-14 10:17AM  Insider Trading Alert - NUVA, TUES And KR Traded By Insiders at TheStreet
09-Jul-14 08:30AM  NuVasive(R) to Participate in the 21st Annual International Meeting on Advanced Spine Techniques (IMAST) Marketwired
07-Jul-14 12:00PM  NuVasive(R) Names Carol Cox Executive Vice President Strategy and Corporate Communications Marketwired
03-Jul-14 10:14AM  Insider Trading Alert - CSC, NUVA And BAS Traded By Insiders at TheStreet
26-Jun-14 09:29AM  Will This Analyst Upgrade Help NuVasive (NUVA) Stock Today? at TheStreet
25-Jun-14 12:30PM  Insider Trading Alert - DVN, NUVA And SWN Traded By Insiders
11:15AM  Insider Trading Alert - DVN, NUVA And SWN Traded By Insiders at TheStreet
23-Jun-14 08:30AM  NuVasive(R) Announces the Release of the Next Generation Monitoring Platform for Spine Surgery Marketwired
29-May-14 07:57AM  NuVasive would have negative read through from Stryker deal, says RBC Capital at theflyonthewall.com
21-May-14 09:50AM  NuVasive management to meet with Piper Jaffray at theflyonthewall.com
09:20AM  Why NuVasive (NUVA) Stock Is Down In Pre-Market Trading Today at TheStreet
06:19AM  NuVasive downgraded to Hold from Buy at Needham at theflyonthewall.com
19-May-14 04:31PM  NUVASIVE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws EDGAR Online
15-May-14 06:10AM  NUVASIVE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
12-May-14 10:00AM  NuVasive, Inc. (NASDAQ: NUVA) to Ring The NASDAQ Stock Market Opening Bell GlobeNewswire
08-May-14 04:30PM  NuVasive(R) to Ring NASDAQ Opening Bell Marketwired
07-May-14 05:00PM  NuVasive(R) Management to Participate in Investor Events in May and June 2014 Marketwired
10:30AM  Insider Trading Alert - NUVA, SWN And NYCB Traded By Insiders at TheStreet
06-May-14 08:30AM  NuVasive(R) Announces Favorable Resolution of Patent Lawsuit Against Cadwell Laboratories, Inc. Marketwired
01-May-14 08:30AM  NuVasive(R) Solutions Recognized for Advancing Spine Technology and Patient Care Marketwired
30-Apr-14 06:32PM  NuVasive Tops Earnings Expectations, but Challenges Remain at Motley Fool
06:05AM  NUVASIVE INC Files SEC form 10-Q, Quarterly Report EDGAR Online
02:42AM  NuVasive's CEO Discusses Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
29-Apr-14 05:30PM  NuVasive CCBN
04:45PM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:37PM  NuVasive Announces Executive Leadership Transition Marketwired
04:30PM  NuVasive Reports First Quarter 2014 Financial Results Marketwired
07:07AM  Q1 2014 NuVasive CCBN
24-Apr-14 12:21PM  Zimmer To Acquire Biomet; Stock Soars at Investor's Business Daily
20-Apr-14 09:08PM  NuVasive poised for vigorous growth at Los Angeles Times
15-Apr-14 04:30PM  NuVasive(R) Announces Conference Call And Webcast of First Quarter 2014 Results Marketwired
14-Apr-14 08:30AM  NuVasive(R) Japan Office Marks One-Year Anniversary of Outstanding Customer and Patient Support Marketwired
08-Apr-14 06:15PM  NuVasive Gets Unfavorable Trademark Verdict Zacks
04-Apr-14 10:15AM  Insider Trading Alert - MPWR, NUVA And ACM Traded By Insiders at TheStreet
06:06AM  NUVASIVE INC Files SEC form 8-K, Other Events EDGAR Online
21-Mar-14 04:30PM  Local Medical Device Company, NuVasive(R), Sponsors the 6th Annual San Diego Festival of Science and Engineering Expo Day Marketwired
04:00PM  NuVasive's Innovative Product Launches To Drive Growth, Stock Has Significant Upside at Seeking Alpha
17-Mar-14 11:52AM  Brian Roberts, the CFO of Insulet Corporation (PODD), Interviews with The Wall Street Transcript Wall Street Transcript
14-Mar-14 01:47PM  Medical Device Use Beginning to Move in Tandem with Genetic Testing: An Exclusive Interview with Tycho W. Peterson, a Senior Analyst in J.P. Morgan's Health Care Group Wall Street Transcript
05-Mar-14 04:20PM  Stryker Continues Acquisition Spree but Shares Fall Zacks
01:31PM  NuVasive price target raised to $45 from $42 at Barrington at theflyonthewall.com
04-Mar-14 04:30PM  NuVasive(R) to Exhibit Comprehensive Spine Portfolio at the 30th Annual Meeting of the AANS/CNS Section on Disorders of the Spine and Peripheral Nerves Marketwired +6.48%
02:00PM  Balanced View Retained for Boston Scientific Zacks
12:01PM  NuVasive Up After Q4 Beat, Despite Cautious Guidance Optionetics
08:30AM  NuVasive(R) Management to Participate in Investor Events in March 2014 Marketwired
02:08AM  NuVasive's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
03-Mar-14 05:30PM  NuVasive CCBN
04:56PM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:30PM  NuVasive Reports Fourth Quarter and Full Year 2013 Financial Results Marketwired
07:07AM  Q4 2013 NuVasive CCBN
25-Feb-14 09:00AM  Wright Medical Group Sees Wider Q4 Loss Zacks
24-Feb-14 07:28AM  ICU Medical (ICUI) Crumbles: Stock Falls by 6.6% Zacks
21-Feb-14 08:30AM  Symmetry Medical Sees In-Line Earnings Zacks
18-Feb-14 04:30PM  NuVasive(R) Solutions Named on Becker's ASC Review List of "100 Minimally Invasive Orthopedic & Spine Devices to Know" Marketwired
14-Feb-14 01:40PM  Will NPS Pharma (NPSP) Miss This Earnings Season? Zacks
13-Feb-14 10:20AM  Marginal Earnings Beat at Hospira in Q4 (Revised) Zacks
12-Feb-14 10:05AM  Marginal Earnings Beat at Hospira in Q4 Zacks
NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for the spine. Its products focus on applications for spine fusion surgery. The company's principal product offering includes a minimally disruptive surgical platform, known Maximum Access Surgery (MAS) that includes its proprietary software-driven nerve detection and avoidance systems, NVM5 and NVJJB, and intra-operative monitoring (IOM) support; MaXcess, an integrated split-blade retractor system; and various specialized implants. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company's biologic product line offerings used to aid the spinal fusion process or bone healing consist of allograft (donated human tissue); Osteocel Plus, an allograft cellular matrix containing viable mesenchymal stem cells; FormaGraft, a collagen synthetic product; and AttraX, a synthetic bone graft material. It also provides IOM services for insight into the nervous system during spine and other surgeries. In addition, the company is developing proprietary total disc replacement devices, which include XL-TDR, a mechanical total disc replacement for lateral lumbar spine applications; and the PCM device for cervical spine applications. It sells its products through independent sales agencies, directly-employed sales shareowners, and distributors to surgeons and hospitals in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Valentine KeithCOOOct 20Option Exercise9.501,33412,67376,119Oct 21 04:57 PM
Valentine KeithCOOOct 20Sale34.9688330,86775,236Oct 21 04:57 PM
Valentine KeithCOOOct 02Sale35.002,50087,50074,785Oct 06 05:00 PM
Valentine KeithPresident & COOSep 02Sale35.142,50087,85077,285Sep 03 04:28 PM
Valentine KeithPresident & COOAug 01Sale37.112,50092,77579,785Aug 05 04:47 PM
LAMBERT MICHAELEVP & CFOAug 01Sale37.114,010148,81113,631Aug 05 04:46 PM
Hannon JasonEVP, General Counsel & Sec.Jul 30Sale39.005,000195,00030,390Jul 31 05:22 PM
Powers RussellEVP, InternationalJul 10Sale33.433,200106,97642,984Jul 11 06:40 PM
LAMBERT MICHAELEVP & CFOJul 01Sale35.4823,225823,93017,641Jul 02 06:50 PM
Valentine KeithPresident & COOJul 01Sale35.652,50089,12582,285Jul 02 06:44 PM
Valentine KeithPresident & COOJun 20Sale35.005,000175,00084,785Jun 24 06:43 PM
Powers RussellEVP, InternationalJun 20Sale35.009,526333,41043,281Jun 24 06:40 PM
HUNT ROBERT JDirectorMay 05Option Exercise18.2320,000364,60054,500May 06 05:05 PM
HUNT ROBERT JDirectorMay 05Sale34.2520,000685,00034,500May 06 05:05 PM
LAMBERT MICHAELEVP & CFOMay 02Sale33.0713,096433,08551,695May 06 04:57 PM
Valentine KeithPresident & COOApr 01Sale38.412,50096,02588,985Apr 03 06:22 PM
MORE EILEEN MDirectorMar 13Option Exercise25.8924,000621,36040,000Mar 17 07:07 PM
FARRELL PETER CDirectorMar 11Option Exercise10.0821,300214,70428,094Mar 12 09:02 PM
MORE EILEEN MDirectorMar 11Sale37.1424,000891,24016,000Mar 17 07:07 PM
FARRELL PETER CDirectorMar 11Sale36.6421,300780,4326,794Mar 12 09:02 PM
FARRELL PETER CDirectorMar 10Option Exercise12.0826,700322,65633,794Mar 12 09:02 PM
FARRELL PETER CDirectorMar 10Sale37.0726,700989,7696,794Mar 12 09:02 PM
HOWE LESLEY HDirectorMar 07Option Exercise18.9515,000284,25020,000Mar 10 05:34 PM
Hannon JasonEVP, Gen. Counsel & SecretaryJan 21Sale36.6010,095369,4678,899Jan 23 09:11 PM
Valentine KeithPresident & COOJan 16Option Exercise18.3120,000366,20064,226Jan 17 09:04 PM
Valentine KeithPresident & COOJan 16Sale37.9620,000759,14044,226Jan 17 09:04 PM
Lukianov Alexis VChairman & CEOJan 08Sale35.164,800168,78250,940Jan 13 05:18 PM
Lukianov Alexis VChairman & CEOJan 07Option Exercise9.5012,217116,06267,957Jan 09 04:54 PM
Lukianov Alexis VChairman & CEOJan 07Sale34.2934,2171,173,45555,740Jan 09 04:54 PM
Hunsaker Craig ESVP, Global Human ResourcesJan 07Sale35.004,980174,30021,142Jan 09 04:18 PM
Hunsaker Craig ESVP, Global Human ResourcesDec 30Sale32.104,275137,21024,980Dec 31 04:24 PM
LAMBERT MICHAELExecutive Vice Pres. & CFODec 23Sale32.4917,091555,22013,096Dec 26 05:03 PM
Lukianov Alexis VChairman & CEONov 07Sale31.455,000157,24072,827Nov 08 08:23 PM
Miles PatrickPres., Global Products & SvcsOct 30Sale31.1021,223660,03510Oct 31 06:15 PM
Hannon JasonEVP, Gen. Counsel & SecretaryOct 30Sale28.902,33467,44517,657Oct 31 06:16 PM
Miles PatrickPres., Global Products & SvcsOct 28Sale25.727,331188,57521,233Oct 29 05:27 PM